Heart Valve Devices Market

1.    Preface
2.    Scope and Methodology
2.1.    Objectives of the Study
2.2.    Stakeholders
2.3.    Data Sources
2.3.1.    Primary Sources
2.3.2.    Secondary Sources
2.4.    Market Estimation
2.4.1.    Bottom-Up Approach
2.4.2.    Top-Down Approach
2.5.    Forecasting Methodology
3.    Executive Summary
4.    Global Heart Valve Devices Market – Introduction
4.1.    What are Heart Valve Devices?
4.1.1.    Introduction
4.1.2.    Major Applications
4.2.    Industry Trends
4.3.    Competitive Intelligence
5.    Global Heart Valve Devices Market Landscape
5.1.    Historical and Current Market Trends (2018-2023)
5.2.    Market Forecast (2024-2032)
6.    Global Heart Valve Devices Market - Breakup by Type
6.1.    Mechanical Heart Valve
6.1.1.    Overview
6.1.2.    Historical and Current Market Trends (2018-2023)
6.1.3.    Market Forecast (2024-2032)
6.1.4.    Market Breakup by End-User 
6.1.5.    Key Players 
6.1.6.    Patent Analysis
6.1.6.1.    Top Patent Applications
6.1.6.2.    Document Type
6.1.6.3.    Jurisdiction Analysis 
6.1.6.4.    Top CPC Codes
6.1.6.5.    Legal status
6.2.    Biological Heart Valve
6.2.1.    Overview
6.2.2.    Historical and Current Market Trends (2018-2023)
6.2.3.    Market Forecast (2024-2032)
6.2.4.    Market Breakup by End-User 
6.2.5.    Key Players 
6.2.6.    Patent Analysis
6.2.6.1.    Top Patent Applications
6.2.6.2.    Document Type
6.2.6.3.    Jurisdiction Analysis 
6.2.6.4.    Top CPC Codes
6.2.6.5.    Legal status
6.3.    Transcatheter Valve
6.3.1.    Overview
6.3.2.    Historical and Current Market Trends (2018-2023)
6.3.3.    Market Forecast (2024-2032)
6.3.4.    Market Breakup by End-User 
6.3.5.    Key Players 
6.3.6.    Patent Analysis
6.3.6.1.    Top Patent Applications
6.3.6.2.    Document Type
6.3.6.3.    Jurisdiction Analysis 
6.3.6.4.    Top CPC Codes
6.3.6.5.    Legal status
6.4.    Attractive Investment Proposition by Type
7.    Global Heart Valve Devices Market – End-User
7.1.    Hospitals
7.1.1.    Overview
7.1.2.    Historical and Current Market Trends (2018-2023)
7.1.3.    Market Breakup by Type
7.1.4.    Market Forecast (2024-2032)
7.2.    Ambulatory Surgical Centres 
7.2.1.    Overview
7.2.2.    Historical and Current Market Trends (2018-2023)
7.2.3.    Market Breakup by Type
7.2.4.    Market Forecast (2024-2032)
7.3.    Others 
7.3.1.    Overview
7.3.2.    Historical and Current Market Trends (2018-2023)
7.3.3.    Market Breakup by Type
7.3.4.    Market Forecast (2024-2032)
7.4.    Attractive Investment Proposition by End-User
8.    Global Heart Valve Devices Market – Breakup by Region
8.1.    North America
8.1.1.    United States
8.1.1.1.    Patient Cases by Therapeutic Area
8.1.1.1.1.    Coronary Heart Disease
8.1.1.1.2.    Stroke 
8.1.1.1.3.    Atrial Fibrillation  
8.1.1.2.    Market Drivers
8.1.1.3.    Historical and Current Market Trends (2018-2023)
8.1.1.4.    Market Breakup by Type
8.1.1.5.    Market Breakup by End-User
8.1.1.6.    Key Players
8.1.1.7.    Market Forecast (2024-2032)
8.1.1.8.    Recent Investments
8.1.1.8.1.    Government Investments
8.1.1.8.2.    Private Investments
8.1.1.9.    Regulatory Approval Process
8.1.1.10.    Pricing Analysis 
8.1.2.    Canada
8.1.2.1.    Market Drivers
8.1.2.2.    Historical and Current Market Trends (2018-2023)
8.1.2.3.    Market Breakup by Type
8.1.2.4.    Market Breakup by End-User
8.1.2.5.    Key Players
8.1.2.6.    Market Forecast (2024-2032)
8.1.2.7.    Recent Investments
8.1.2.7.1.    Government Investments
8.1.2.7.2.    Private Investments
8.1.2.8.    Regulatory Approval Process
8.1.2.9.    Pricing Analysis 
8.2.    Europe
8.2.1.    Germany
8.2.1.1.    Patient Cases by Therapeutic Area
8.2.1.1.1.    Coronary Heart Disease
8.2.1.1.2.    Stroke 
8.2.1.1.3.    Atrial Fibrillation   
8.2.1.2.    Market Drivers
8.2.1.3.    Historical and Current Market Trends (2018-2023)
8.2.1.4.    Market Breakup by Type
8.2.1.5.    Market Breakup by End-User
8.2.1.6.    Key Players
8.2.1.7.    Market Forecast (2024-2032)
8.2.1.8.    Recent Investments
8.2.1.8.1.    Government Investments
8.2.1.8.2.    Private Investments
8.2.1.9.    Regulatory Approval Process
8.2.1.10.    Pricing Analysis 
8.2.2.    France
8.2.2.1.    Patient Cases by Therapeutic Area
8.2.2.1.1.    Coronary Heart Disease
8.2.2.1.2.    Stroke 
8.2.2.1.3.    Atrial Fibrillation   
8.2.2.2.    Market Drivers
8.2.2.3.    Historical and Current Market Trends (2018-2023)
8.2.2.4.    Market Breakup by Type
8.2.2.5.    Market Breakup by End-User
8.2.2.6.    Key Players
8.2.2.7.    Market Forecast (2024-2032)
8.2.2.8.    Recent Investments
8.2.2.8.1.    Government Investments
8.2.2.8.2.    Private Investments
8.2.2.9.    Regulatory Approval Process
8.2.2.10.    Pricing Analysis 
8.2.3.    United Kingdom
8.2.3.1.    Patient Cases by Therapeutic Area
8.2.3.1.1.    Coronary Heart Disease
8.2.3.1.2.    Stroke 
8.2.3.1.3.    Atrial Fibrillation   
8.2.3.2.    Market Drivers
8.2.3.3.    Historical and Current Market Trends (2018-2023)
8.2.3.4.    Market Breakup by Type
8.2.3.5.    Market Breakup by End-User
8.2.3.6.    Key Players
8.2.3.7.    Market Forecast (2024-2032)
8.2.3.8.    Recent Investments
8.2.3.8.1.    Government Investments
8.2.3.8.2.    Private Investments
8.2.3.9.    Regulatory Approval Process
8.2.3.10.    Pricing Analysis      
8.2.4.    Italy
8.2.4.1.    Patient Cases by Therapeutic Area
8.2.4.1.1.    Coronary Heart Disease
8.2.4.1.2.    Stroke 
8.2.4.1.3.    Atrial Fibrillation   
8.2.4.2.    Market Drivers
8.2.4.3.    Historical and Current Market Trends (2018-2023)
8.2.4.4.    Market Breakup by Type
8.2.4.5.    Market Breakup by End-User
8.2.4.6.    Key Players
8.2.4.7.    Market Forecast (2024-2032)
8.2.4.8.    Recent Investments
8.2.4.8.1.    Government Investments
8.2.4.8.2.    Private Investments
8.2.4.9.    Regulatory Approval Process
8.2.4.10.    Pricing Analysis      
8.2.5.    Spain
8.2.5.1.    Patient Cases by Therapeutic Area
8.2.5.1.1.    Coronary Heart Disease
8.2.5.1.2.    Stroke 
8.2.5.1.3.    Atrial Fibrillation   
8.2.5.2.    Market Drivers
8.2.5.3.    Historical and Current Market Trends (2018-2023)
8.2.5.4.    Market Breakup by Type
8.2.5.5.    Market Breakup by End-User
8.2.5.6.    Key Players
8.2.5.7.    Market Forecast (2024-2032)
8.2.5.8.    Recent Investments
8.2.5.8.1.    Government Investments
8.2.5.8.2.    Private Investments
8.2.5.9.    Regulatory Approval Process
8.2.5.10.    Pricing Analysis      
8.2.6.    Others
8.2.6.1.    Historical and Current Market Trends (2018-2023)
8.2.6.2.    Market Forecast (2024-2032)
8.3.    Asia Pacific 
8.3.1.    China
8.3.1.1.    Market Drivers
8.3.1.2.    Historical and Current Market Trends (2018-2023)
8.3.1.3.    Market Breakup by Type
8.3.1.4.    Market Breakup by End-User
8.3.1.5.    Key Players
8.3.1.6.    Market Forecast (2024-2032)
8.3.1.7.    Recent Investments
8.3.1.7.1.    Government Investments
8.3.1.7.2.    Private Investments
8.3.1.8.    Regulatory Approval Process
8.3.1.9.    Pricing Analysis      
8.3.2.    Japan
8.3.2.1.    Patient Cases by Therapeutic Area
8.3.2.1.1.    Coronary Heart Disease
8.3.2.1.2.    Stroke 
8.3.2.1.3.    Atrial Fibrillation   
8.3.2.2.    Market Drivers
8.3.2.3.    Historical and Current Market Trends (2018-2023)
8.3.2.4.    Market Breakup by Type
8.3.2.5.    Market Breakup by End-User
8.3.2.6.    Key Players
8.3.2.7.    Market Forecast (2024-2032)
8.3.2.8.    Recent Investments
8.3.2.8.1.    Government Investments
8.3.2.8.2.    Private Investments
8.3.2.9.    Regulatory Approval Process
8.3.2.10.    Pricing Analysis     
8.3.3.    India
8.3.3.1.    Market Drivers
8.3.3.2.    Historical and Current Market Trends (2018-2023)
8.3.3.3.    Market Breakup by Type
8.3.3.4.    Market Breakup by End-User
8.3.3.5.    Key Players
8.3.3.6.    Market Forecast (2024-2032)
8.3.3.7.    Recent Investments
8.3.3.7.1.    Government Investments
8.3.3.7.2.    Private Investments
8.3.3.8.    Regulatory Approval Process
8.3.3.9.    Pricing Analysis     
8.3.4.    South Korea
8.3.4.1.    Market Drivers
8.3.4.2.    Historical and Current Market Trends (2018-2023)
8.3.4.3.    Market Breakup by Type
8.3.4.4.    Market Breakup by End-User
8.3.4.5.    Key Players
8.3.4.6.    Market Forecast (2024-2032)
8.3.4.7.    Recent Investments
8.3.4.7.1.    Government Investments
8.3.4.7.2.    Private Investments
8.3.4.8.    Regulatory Approval Process
8.3.4.9.    Pricing Analysis     
8.3.5.    Australia
8.3.5.1.    Market Drivers
8.3.5.2.    Historical and Current Market Trends (2018-2023)
8.3.5.3.    Market Breakup by Type
8.3.5.4.    Market Breakup by End-User
8.3.5.5.    Key Players
8.3.5.6.    Market Forecast (2024-2032)
8.3.5.7.    Recent Investments
8.3.5.7.1.    Government Investments
8.3.5.7.2.    Private Investments
8.3.5.8.    Regulatory Approval Process
8.3.5.9.    Pricing Analysis     
8.3.6.    Indonesia
8.3.6.1.    Market Drivers
8.3.6.2.    Historical and Current Market Trends (2018-2023)
8.3.6.3.    Market Breakup by Type
8.3.6.4.    Market Breakup by End-User
8.3.6.5.    Key Players
8.3.6.6.    Market Forecast (2024-2032)
8.3.6.7.    Recent Investments
8.3.6.7.1.    Government Investments
8.3.6.7.2.    Private Investments
8.3.6.8.    Regulatory Approval Process
8.3.6.9.    Pricing Analysis 
8.3.7.    Others
8.3.7.1.    Historical and Current Market Trends (2018-2023)
8.3.7.2.    Market Forecast (2024-2032)
8.4.    Latin America
8.4.1.    Brazil
8.4.1.1.    Market Drivers
8.4.1.2.    Historical and Current Market Trends (2018-2023)
8.4.1.3.    Market Breakup by Type
8.4.1.4.    Market Breakup by End-User
8.4.1.5.    Key Players
8.4.1.6.    Market Forecast (2024-2032)
8.4.1.7.    Recent Investments
8.4.1.7.1.    Government Investments
8.4.1.7.2.    Private Investments
8.4.1.8.    Regulatory Approval Process
8.4.1.9.    Pricing Analysis
8.4.2.    Mexico
8.4.2.1.    Market Drivers
8.4.2.2.    Historical and Current Market Trends (2018-2023)
8.4.2.3.    Market Breakup by Type
8.4.2.4.    Market Breakup by End-User
8.4.2.5.    Key Players
8.4.2.6.    Market Forecast (2024-2032)
8.4.2.7.    Recent Investments
8.4.2.7.1.    Government Investments
8.4.2.7.2.    Private Investments
8.4.2.8.    Regulatory Approval Process
8.4.2.9.    Pricing Analysis
8.4.3.    Others
8.4.3.1.    Historical and Current Market Trends (2018-2023)
8.4.3.2.    Market Forecast (2024-2032)
8.5.    Middle East
8.5.1   Market Drivers
8.5.2    Historical and Current Market Trends (2018-2023)
8.5.3    Market Breakup by Type
8.5.4    Market Breakup by End-User
8.5.5    Market Breakup by Country
8.5.6    Key Players
8.5.7    Market Forecast (2024-2032)
8.5.8    Recent Investments
8.5.8.1    Government Investments
8.5.8.2.    Private Investments
8.5.9     Regulatory Approval Process
8.5.10    Pricing Analysis
8.6.    Africa
8.6.1    Market Drivers
8.6.2    Historical and Current Market Trends (2018-2023)
8.6.3    Market Breakup by Type
8.6.4    Market Breakup by Application
8.6.5    Market Breakup by Country
8.6.6    Key Players
8.6.7    Market Forecast (2024-2032)
8.6.8    Recent Investments
8.6.8.1    Government Investments
8.6.8.2    Private Investments
8.6.11    Regulatory Approval Process
8.6.12    Pricing Analysis
8.7.    Attractive Investment Proposition by Region
9.    Technology Analysis 
9.1.    Overview of Different Technologies
9.2.    Technology wise Applications
9.3.    Time to Market for New Product
9.4.    Key Technology Trends
9.4.1.    Development of Novel Materials for Heart Valve Replacements
9.4.2.    Tissue Valves
10.    Government Regulations and Strategies
10.1.    Medical Device Regulation (MDR) 
10.2.    CE Marking (European Union) 
10.3.    ISO Standards Compliance
11.    Global Heart Valve Devices Market - Industry Analysis
11.1.    Drivers, Restraints, and Opportunities
11.1.1.    Overview
11.1.2.    Drivers
11.1.2.1.    Increasing Prevalence of Heart Diseases
11.1.2.2.    Growing Aging Population
11.1.3.    Restraints
11.1.3.1.    High Cost and Poor Reimbursement      
11.1.4.    Opportunities
11.1.4.1.    New Improved Materials for Heart Values
11.1.5.    Impact Analysis
11.2.    Porters Five Forces Analysis
11.2.1.    Overview
11.2.2.    Bargaining Power of Buyers
11.2.3.    Bargaining Power of Suppliers
11.2.4.    Degree of Competition
11.2.5.    Threat of New Entrants
11.2.6.    Threat of Substitutes
11.3.    Value Chain Analysis
12.    Global Heart Valve Devices Market – Competitive Landscape
12.1.    Overview
12.2.    Market Structure
12.3.    Market Share by Key Players
12.4.    Market Player Positioning
12.5.    Top Winning Strategies
12.6.    Competitive Dashboard
12.7.    Company Evaluation Quadrant
13.    Profiles of Key Players
13.1.    Abbott 
13.1.1.    Business Overview
13.1.2.    Products Offered
13.1.3.    Business Strategies
13.1.3.1.    Marketing Strategy
13.1.3.2.    Product Strategy
13.1.3.3.    Channel Strategy
13.1.4.    Financials
13.1.5.    SWOT Analysis
13.1.6.    Major News and Events
13.2.    Boston Scientific Corporation
13.2.1.    Business Overview
13.2.2.    Products Offered
13.2.3.    Business Strategies
13.2.3.1.    Marketing Strategy
13.2.3.2.    Product Strategy
13.2.3.3.    Channel Strategy
13.2.4.    Financials
13.2.5.    SWOT Analysis
13.2.6.    Major News and Events
13.3.    Lifescan
13.3.1.    Business Overview
13.3.2.    Products Offered
13.3.3.    Business Strategies
13.3.3.1.    Marketing Strategy
13.3.3.2.    Product Strategy
13.3.3.3.    Channel Strategy
13.3.4.    SWOT Analysis
13.3.5.    Major News and Events
13.4.    CryoLife
13.4.1.            13.4.1 Business Overview
13.4.2.    Products Offered
13.4.3.    Business Strategies
13.4.3.1.    Marketing Strategy
13.4.3.2.    Product Strategy
13.4.3.3.    Channel Strategy
13.4.4.    SWOT Analysis
13.4.5.    Major News and Events
13.5.    Edward Lifesciences Corporation
13.5.1.    Business Overview
13.5.2.    Products Offered
13.5.3.    Business Strategies
13.5.3.1.    Marketing Strategy
13.5.3.2.    Product Strategy
13.5.3.3.    Channel Strategy
13.5.4.    SWOT Analysis
13.5.5.    Major News and Events
13.6.    Medtronic
13.6.1.    Business Overview
13.6.2.    Products Offered
13.6.3.    Business Strategies
13.6.3.1.    Marketing Strategy
13.6.3.2.    Product Strategy
13.6.3.3.    Channel Strategy
13.6.4.    Major News and Events
13.7.    JenaValue Technology
13.7.1.    Business Overview
13.7.2.    Products Offered
13.7.3.    Business Strategies
13.7.3.1.    Marketing Strategy
13.7.3.2.    Product Strategy
13.7.3.3.    Channel Strategy
13.7.4.    SWOT Analysis
13.7.5.    Major News and Events
13.8.    SYMETIS
13.8.1.    Business Overview
13.8.2.    Products Offered
13.8.3.    Business Strategies
13.8.3.1.    Marketing Strategy
13.8.3.2.    Product Strategy
13.8.3.3.    Channel Strategy
13.8.4.    SWOT Analysis
13.8.5.    Major News and Events
13.9.    Neovasc
13.9.1.    Business Overview
13.9.2.    Products Offered
13.9.3.    Business Strategies
13.9.3.1.    Marketing Strategy
13.9.3.2.    Product Strategy
13.9.3.3.    Channel Strategy
13.9.4.    SWOT Analysis
13.9.5.    Major News and Events
13.10.    Sorin Group 
13.10.1.    Business Overview
13.10.2.     Product Portfolio
13.10.3.     Business Strategies
13.10.3.1.    Marketing Strategy
13.10.3.2.    Product Strategy
13.10.3.3.    Channel Strategy
13.10.4.    SWOT Analysis
13.10.5.    Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

14.    Strategic Recommendations
15.    Appendix